Literature DB >> 3766417

Evidence for progression from mild to severe mitral regurgitation in mitral valve prolapse.

A J Kolibash, J W Kilman, C A Bush, J M Ryan, M E Fontana, C F Wooley.   

Abstract

Little information is available concerning the progression of mild to severe mitral regurgitation (MR) in patients with mitral valve prolapse (MVP). This study reports 86 patients, average age 60 years, who presented with cardiac symptoms, precordial systolic murmur, severe MR and a high incidence of MVP on echocardiography (57 of 75 [75%] ) and left ventriculography (61 of 84 [73%] ). Seventy-five surgically excised mitral valves appeared grossly enlarged and floppy. Histologic studies showed extensive myxomatous changes throughout the leaflets and chordae. Eighty patients had had precordial murmurs first described at average age 34 years, but the average age at which symptoms of cardiac dysfunction appeared was 59. However, once symptoms developed, mitral valve surgery was required within 1 year in 67 of 76 patients who had undergone surgery. Atrial fibrillation, present in 48 of 86 patients (56%), or ruptured chordae tendineae, present in 39 of 76 patients (51%), may have contributed to this rapid progression and deterioration. Additionally, 13 patients had a remote history of documented infective endocarditis. Twenty-eight patients had at least 1 type of serial clinical evaluation that indicated progressive MR in all 28 patients on the basis of changing auscultatory findings (24 of 26), progressive radiographic cardiomegaly (24 of 25), echocardiographic left atrial enlargement (4.3 to 5 cm in 11 patients) and angiographically worsening MR (14 of 15). Twenty-four of these patients had evidence of MVP on at least 1 of their initial studies. Thus, mild MR due to MVP and myxomatous mitral valves is a progressive disease in some patients with MVP.

Entities:  

Mesh:

Year:  1986        PMID: 3766417     DOI: 10.1016/0002-9149(86)90352-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

Review 1.  Mitral valve disease--morphology and mechanisms.

Authors:  Robert A Levine; Albert A Hagége; Daniel P Judge; Muralidhar Padala; Jacob P Dal-Bianco; Elena Aikawa; Jonathan Beaudoin; Joyce Bischoff; Nabila Bouatia-Naji; Patrick Bruneval; Jonathan T Butcher; Alain Carpentier; Miguel Chaput; Adrian H Chester; Catherine Clusel; Francesca N Delling; Harry C Dietz; Christian Dina; Ronen Durst; Leticia Fernandez-Friera; Mark D Handschumacher; Morten O Jensen; Xavier P Jeunemaitre; Hervé Le Marec; Thierry Le Tourneau; Roger R Markwald; Jean Mérot; Emmanuel Messas; David P Milan; Tui Neri; Russell A Norris; David Peal; Maelle Perrocheau; Vincent Probst; Michael Pucéat; Nadia Rosenthal; Jorge Solis; Jean-Jacques Schott; Ehud Schwammenthal; Susan A Slaugenhaupt; Jae-Kwan Song; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2015-10-20       Impact factor: 32.419

2.  Mitral valve prolapse.

Authors:  M S Zua
Journal:  J Natl Med Assoc       Date:  1996-04       Impact factor: 1.798

3.  Mitral valve prolapse.

Authors:  T O Cheng
Journal:  J Natl Med Assoc       Date:  1995-11       Impact factor: 1.798

4.  Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome.

Authors:  Andrew J Kim; Na Xu; Kazuhiro Umeyama; Alexia Hulin; Sithara Raju Ponny; Ronald J Vagnozzi; Ellis A Green; Paul Hanson; Bruce M McManus; Hiroshi Nagashima; Katherine E Yutzey
Journal:  Circulation       Date:  2020-01-13       Impact factor: 29.690

5.  Mitral Regurgitation: Current Treatment Options and Their Selection.

Authors:  Jeffrey S Borer; Katie Kupfer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-12

Review 6.  The mitral valve prolapse epidemic: fact or fiction.

Authors:  R P Lewis; C F Wooley; A J Kolibash; H Boudoulas
Journal:  Trans Am Clin Climatol Assoc       Date:  1987

Review 7.  Genetics of valvular heart disease.

Authors:  Stephanie LaHaye; Joy Lincoln; Vidu Garg
Journal:  Curr Cardiol Rep       Date:  2014       Impact factor: 2.931

8.  Evolution of Mitral Valve Prolapse: Insights From the Framingham Heart Study.

Authors:  Francesca N Delling; Jian Rong; Martin G Larson; Birgitta Lehman; Deborah Fuller; Ewa Osypiuk; Plamen Stantchev; Brianne Hackman; Warren J Manning; Emelia J Benjamin; Robert A Levine; Ramachandran S Vasan
Journal:  Circulation       Date:  2016-03-22       Impact factor: 29.690

9.  Mutations in DCHS1 cause mitral valve prolapse.

Authors:  Ronen Durst; Kimberly Sauls; David S Peal; Annemarieke deVlaming; Katelynn Toomer; Maire Leyne; Monica Salani; Michael E Talkowski; Harrison Brand; Maëlle Perrocheau; Charles Simpson; Christopher Jett; Matthew R Stone; Florie Charles; Colby Chiang; Stacey N Lynch; Nabila Bouatia-Naji; Francesca N Delling; Lisa A Freed; Christophe Tribouilloy; Thierry Le Tourneau; Hervé LeMarec; Leticia Fernandez-Friera; Jorge Solis; Daniel Trujillano; Stephan Ossowski; Xavier Estivill; Christian Dina; Patrick Bruneval; Adrian Chester; Jean-Jacques Schott; Kenneth D Irvine; Yaopan Mao; Andy Wessels; Tahirali Motiwala; Michel Puceat; Yoshikazu Tsukasaki; Donald R Menick; Harinath Kasiganesan; Xingju Nie; Ann-Marie Broome; Katherine Williams; Amanda Johnson; Roger R Markwald; Xavier Jeunemaitre; Albert Hagege; Robert A Levine; David J Milan; Russell A Norris; Susan A Slaugenhaupt
Journal:  Nature       Date:  2015-08-10       Impact factor: 49.962

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.